VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of fibronectin.

Yusuke Nojima(Osaka Prefecture University), Chikao Morimoto(Juntendo University), Martin J. Humphries(Wellcome Centre for Cell-Matrix Research), Kenneth M. Yamada(National Institute of Dental and Craniofacial Research), S F Schlossman(Dana-Farber Cancer Institute), Akira Komoriya(OncoImmune (United States)), A. Paul Mould(University of Manchester)
The Journal of Experimental Medicine
October 1, 1990
Cited by 219


Related Papers